Renal tubular peptide catabolism in chronic vascular rejection

Renal Failure

Volumn 23, Issue 3-4, 2001, Pages 517-531

  Rustom, Rana ^a,b   Grime, J Steve ^c   Sells, R A ^b   Amara, A ^c   Jackson, M J ^b   Shenkin, Alan ^c   Maltby, Paul ^c   Smith, Linda ^c   Hammad, A ^b   Brown, M ^b   Bone, J Michael ^b  

^a Clinical Department   (United Kingdom)

^b University Department of Medicine   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Acidosis; Ammonia; Aprotinin; Chronic vascular rejection; Lisinopril; NAG; Proteinuria; Proximal tubular peptide hypercatabolism

Indexed keywords

AMMONIA; APROTININ; BICARBONATE; LISINOPRIL; N ACETYL BETA GLUCOSAMINIDASE; PEPTIDE; PHYTATE TC 99M;

ACIDOSIS; ADULT; CATABOLISM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HYPERKALEMIA; KIDNEY BLOOD FLOW; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DAMAGE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEINURIA; URINE LEVEL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; APROTININ; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LISINOPRIL; MALE; MIDDLE AGED; PROTEINURIA; SODIUM BICARBONATE; URINE;

EID: 0034920841     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100104734     Document Type: Conference Paper

References (33)

1. Immunologic and non-immunologic factors. Different risk factors for cadaver and living donor transplantation
2. Chronic vascular rejection of the heart and the kidney - Have rational treatment options emerged?
3. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure
4. Tubular metabolism of Aprotinin 99mTc and urinary ammonia; Effects of proteinuria
5. Pathophysiology of chronic tubuo-interstitial disease in rats, interactions of dietary acid load, ammonia, and complement C3
6. A new method to measure renal tubular degradation of small filtered proteins in man using radiolabelled Aprotinin
7. Observations of the early renal uptake and later metabolism of radiolabelled aprotinin in man: Theoretical and practical considerations
8. Renal tubular degradation of radiolabelled Aprotinin (Trasylol) in chronic renal failure patients
9. 99mTc-aprotinin: A new tracer for kidney morphology and function
10. 99mTc-Aprotinin for the study of renal morphology and tubular function
11. Proximal renal tubular peptide catabolism, ammonia excretion, and tubular injury in proteinuric patients: Before and after Lisinopril
12. 3 reduces proximal renal tubular peptide catabolism, ammoniagenesis and tubular damage in renal patients
13. The antiproteinuric effect of angiotensin converting enzyme inhibitors in human renal disease
14. Additive antiproteinuric effect of angiotensin converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: A clue to the mechanism of action
15. ACE-inhibitors: Panacea for progressive renal disease?
16. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy
17. Role of the kidney in plasma albumin catabolism
18. Albumin metabolism in the nephrotic syndrome in adults
19. Metabolism of albumin and immunoglobulins in the nephrotic syndrome
20. The return of glomerular-filtered albumin to the rat renal vein
21. Renal filtration, transport and metabolism of proteins
22. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
23. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
24. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
25. Angiotensin II stimulates ammoniagenesis in canine renal proximal tubule segments
26. Molecular mechanisms of angiotensin II in the kidney: Emerging role in the progression of renal disease: Beyond hemodynamics
27. Hypo-hyperkalemia
28. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases
29. 2α and the implications for other hormones
30. Enalapril (MK 421) in the treatment of hypertension with renal artery stenosis
31. Antihypertensive therapy with MK421: Angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade
32. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and naturieuresis